Subject matters | Details | Categories |
---|---|---|
Industry
|
Amendments to Copyright Act, regarding Technology Protection Measures (TPMs)
|
Legislative Proposal, Bill or Resolution
|
Health
|
Engage in pre-market and post-market regulatory requirements to ensure efficient and predictable processes that supports safety, effectiveness, quality, and Canada’s competitiveness in the medical device sector.
|
Regulation
|
Health
|
Medical device cost recovery schemes with respect to filing fees
|
Policies or Program
|
Environment
|
Substances addressed in the third phase of the Chemicals Management Plan.
|
Policies or Program
|
Industry
|
Support from ISED, with respect to Strategic Innovation Fund
|
Grant, Contribution or Other Financial Benefit
|
GE HealthCare is a leading global medical technology, pharmaceutical diagnostics, and digital solutions innovator, dedicated to providing integrated solutions, services, and data analytics to make hospitals more efficient, clinicians more effective, therapies more precise, and patients healthier and happier. Serving patients and providers for more than 100 years, GE HealthCare is advancing personalized, connected, and compassionate care, while simplifying the patient’s journey across the care pathway. Together our Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics businesses help improve patient care from prevention and screening, to diagnosis, treatment, therapy, and monitoring.
MICHAEL HAMILTON, President and Chief Executive Officer
End date of the last completed financial year: 2023-12-31
Government Institution | Funding Received in Last Financial Year | Funding Expected in Current Financial Year |
---|---|---|
Digital Supercluster (Innovation, Science and Economic Development Canada) | $218,399.00 | Yes |
Address:
1919 Minnesota Court
Mississauga, ON L5N 0C9
Canada
Telephone number:
416-347-4189
GE HealthCare Technologies Canada does not have any subsidiaries that could have a direct interest in the outcome of the undertaking